Science and Self: Monitoring Response to MS Treatment with Biomarkers and Patient-Reported Outcomes

Access Activity

Overview / Abstract:

Target Audience
This activity is designed to meet the educational needs of neurologists, nurse practitioners, PAs, nursing professionals, pharmacists, and other members of the healthcare team essential to the care of patients living with MS.

Program Overview
This enduring activity is designed to review the role of biomarkers and patient-reported outcomes (PROs) in the management of people living with multiple sclerosis (MS).

Learning Objectives
Upon completion of this activity, participants should be better able to:

Review current research and emerging data on biomarkers as potential tool for measuring treatment response in MS patients
Identify patient-reported outcomes and tools that can be incorporated into the clinical setting to measure response to MS treatment

Expiration

Dec 15, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

1.0

Accreditation

ACCME, ACPE, ANCC

Presenters / Authors / Faculty

Edward J. Fox, MD, PhD

Sponsors / Supporters / Grant Providers

Bristol Myers Squibb and Novartis Pharmaceuticals Corporation

Keywords / Search Terms

Relias LLC Relias, Free CME, MS Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map